Financials
- Market Capitalization 92.38 M
- Employee 78
- Founded 2006
- CEO Lindsay Rosenwald
- Website www.fortressbiotech.com
- Headquarter Delaware, United States
- FIGI BBG001J2MFH6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-52.29
Relación precio/flujo de caja
1.61
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3947 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 3.98 USD | -2.93% | -2.69% | +19.88% | -61.09% | 94.74 M USD | ||
| 3974 | PYPD PolyPid Ltd. - Ordinary Shares | 5.07 USD | -0.98% | -0.98% | +20.43% | +50.45% | 92.29 M USD | ||
| 3980 | ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.03 USD | -2.38% | -5.15% | +16.67% | -38.78% | 90.64 M USD | ||
| 3983 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.51 USD | -1.95% | -1.95% | -4.43% | -74.23% | 91.09 M USD |